[º¸°ÇŸÀÓÁî] ¿¬¼¼´ë ÀÇ°ú´ëÇÐ ÈäºÎ¿Ü°úÇб³½Ç ½ÅÈ«ÁÖ ±³¼ö(»çÁø)°¡ Áö³´Þ 29ÀϺÎÅÍ 4ÀÏ°£ ¼¿ï ÄÚ¿¢½º¿¡¼ ¿¸° Á¦12Â÷ ¼¼°èÁßȯÀÚÀÇÇÐ(WFSICCM) Çмú´ëȸ¿¡¼ ÀþÀº ÀÇÇÐÀÚ»ó(Young Investigator Award)À» ¼ö»óÇß´Ù.
½Å ±³¼ö´Â ÀÌ Çмú´ëȸ¿¡¼ ‘±Þ¼ºÀü°Ý¼º ½É±Ù¿°¿¡ °É¸° ȯ¾Æ¿¡¼ ½ÃÇàµÈ ECMO(ü¿Ü¸· »ê¼ÒÈÀåÄ¡)ÀÇ ÃÖ±Ù ÀÓ»ó¼ºÀû(RECENT CLINICAL OUTCOME IN CHILDREN WITH ACUTE FULMINANT MYOCARDITIS SUPPORTED BY MECHANICAL CIRCULATORY SUPPORT)’À̶õ ³í¹®À» ¹ßÇ¥ÇØ Å« ÁÖ¸ñÀ» ¹Þ¾Ò´Ù.
ÃÖ±Ù ±Þ¼ºÀü°Ý¼º ½É±Ù¿°ÀÌ °É¸° ȯ¾Æµé¿¡°Ô ½ÃÇàµÈ ¼¼°è °¢±¹ÀÇ ECMO ¹ßÇ¥ ¼ºÀû¿¡ µû¸£¸é 2011³â ¹Ì±¹Àº »ýÁ¸À² 67~80%, 2011³â ´ë¸¸Àº 71%, ELSO(Extracorporeal Life Support Organization, ¼¼°è ECMO ÇÐȸ)´Â 61%¸¦ º¸¿´´Ù.
±¹³» ´ëÇк´¿øÀº 54% ¼öÁØÀ» ³ªÅ¸³Â´Ù.
ÇÏÁö¸¸ ¼¼ºê¶õ½ºº´¿øÀº 2013³â 4¿ùºÎÅÍ 2³â µ¿¾È 13¸íÀÇ ÇÑÀÚ¿¡°Ô ECMO¸¦ ½ÃÇà, ½ÉÀåÀ̽Ä2·Ê¸¦ Á¦¿ÜÇÏ°í´Â ¸ðµç ȯÀÚ°¡ ÀÌÅ»ÇÒ ¼ö ÀÖ¾ú´Ù.
ÀÌ °¡¿îµ¥ 12¸íÀÌ »ýÁ¸, 92.3%¶ó´Â ³ôÀº »ýÁ¸À²À» ³ªÅ¸³Â´Ù.
»ç¸ÁÇÑ 1¸íµµ ECMO ½Ã¼úÀ̳ª, ½É±Ù¿°°ú´Â »ó°ü¼ºÀ» °®°í ÀÖÁö ¾Ê¾Ò´Ù.
WFSICCM´Â ÇöÀç Àü ¼¼°è 58°³±¹ 65°³ ÇÐȸ(64°³ ÀÇÇÐȸ¿Í 1°³ °£È£ÇÐȸ)·Î ±¸¼ºµÅ 5¸¸ 5,000¿©¸í ÀÌ»óÀÇ È¸¿øÀ» º¸À¯ÇÏ°í ÀÖ´Ù.